1) post-marketing drug
药品上市后
1.
Safety surveillance of post-marketing drugs is designed to observe the possible adverse side effects.
药品上市后的安全性监测主要是对药品的不良反应进行继续观察。
3) study on post-marketing drug
药品上市后研究
1.
Introduced the limitations of pro-marketing drug,the variety and complexity and irrationality of drug usage,the analysis of study on post-marketing drug in domestic or overseas.
药品上市后研究已经成为社会各界广泛关注的焦点。
5) Listed drug
上市药品
6) post-marketing drug assessment
药品上市后再评价
1.
Many countries around the world pay more attention to post-marketing drug assessment and have established post-marketing drug monitoring system and reevaluatio.
药品上市后再评价是依据医药学最新的学术水平,从临床医学、药物流行病学、药物遗传学、药理学、药剂学、药物经济学及药物政策等方面,对已批准上市的药物在广泛人群中的疗效、安全性、用药方案等是否符合安全、有效、经济的合理用药原则做出科学评价,以最大限度地发挥药物防病治病作用。
补充资料：药品
1.药物和化学试剂的总称。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条